BIOMAT Database Logo BIOMAT Database Logo

Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. 1994

K Okamoto, and S Toyokuni, and K Uchida, and O Ogawa, and J Takenewa, and Y Kakehi, and H Kinoshita, and Y Hattori-Nakakuki, and H Hiai, and O Yoshida
Department of Urology, Faculty of Medicine, Kyoto University, Japan.

To study the possible involvement of reactive oxygen species (ROS) in the tumor biology of human renal-cell carcinoma (RCC), we analyzed 35 cases of RCC for 2 parameters of oxidative damage: 8-hydroxy-2'-deoxyguanosine (8-OHdG), a mutation-prone DNA-base-modified product, was measured by means of high-performance liquid chromatography (HPLC) with an electrochemical (EC) detector, and 4-hydroxy-2-nonenal (HNE)-modified proteins were measured with a polyclonal antibody against HNE-modified proteins. A 54% higher content of 8-OHdG was found in RCC than in the corresponding non-tumorous kidney, suggesting that the DNA of RCC is more exposed to ROS than is the DNA of non-tumorous kidneys. Immunohistochemistry for HNE-modified proteins showed a distinct staining pattern of fine to coarse granularity in the cytoplasm of RCC (n = 15), implying that lipid peroxidation products are located in cytoplasmic organelles. These results suggest that RCC constitutionally elaborates more ROS than is produced by the non-tumorous parts of kidneys. No correlation was found between clinical stage, histology, age or sex and the 2 parameters examined.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D003849 Deoxyguanosine A nucleoside consisting of the base guanine and the sugar deoxyribose.
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D005260 Female Females

Related Publications

K Okamoto, and S Toyokuni, and K Uchida, and O Ogawa, and J Takenewa, and Y Kakehi, and H Kinoshita, and Y Hattori-Nakakuki, and H Hiai, and O Yoshida
Heat shock preconditioning reduces the formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal modified proteins in ischemia-reperfused liver of rats.
February 2002, Free radical research,
K Okamoto, and S Toyokuni, and K Uchida, and O Ogawa, and J Takenewa, and Y Kakehi, and H Kinoshita, and Y Hattori-Nakakuki, and H Hiai, and O Yoshida
Formation of 8-hydroxy-2'-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in rat liver after ischemia-reperfusion: distinct localization of the two oxidatively modified products.
January 2000, Antioxidants & redox signaling,
K Okamoto, and S Toyokuni, and K Uchida, and O Ogawa, and J Takenewa, and Y Kakehi, and H Kinoshita, and Y Hattori-Nakakuki, and H Hiai, and O Yoshida
Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart.
March 1999, The American journal of physiology,
K Okamoto, and S Toyokuni, and K Uchida, and O Ogawa, and J Takenewa, and Y Kakehi, and H Kinoshita, and Y Hattori-Nakakuki, and H Hiai, and O Yoshida
Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro.
November 1986, Cancer research,
K Okamoto, and S Toyokuni, and K Uchida, and O Ogawa, and J Takenewa, and Y Kakehi, and H Kinoshita, and Y Hattori-Nakakuki, and H Hiai, and O Yoshida
Selective Identification and Site-Specific Quantification of 4-Hydroxy-2-nonenal-Modified Proteins.
April 2019, Analytical chemistry,
K Okamoto, and S Toyokuni, and K Uchida, and O Ogawa, and J Takenewa, and Y Kakehi, and H Kinoshita, and Y Hattori-Nakakuki, and H Hiai, and O Yoshida
Localization of 4-hydroxy-2-nonenal-modified proteins in kidney following iron overload.
May 1999, Free radical biology & medicine,
K Okamoto, and S Toyokuni, and K Uchida, and O Ogawa, and J Takenewa, and Y Kakehi, and H Kinoshita, and Y Hattori-Nakakuki, and H Hiai, and O Yoshida
Formation of deoxyguanosine cross-links from calf thymus DNA treated with acrolein and 4-hydroxy-2-nonenal.
November 2010, Chemical research in toxicology,
K Okamoto, and S Toyokuni, and K Uchida, and O Ogawa, and J Takenewa, and Y Kakehi, and H Kinoshita, and Y Hattori-Nakakuki, and H Hiai, and O Yoshida
Proteomic analysis of nitrated and 4-hydroxy-2-nonenal-modified serum proteins during aging.
April 2006, The journals of gerontology. Series A, Biological sciences and medical sciences,
K Okamoto, and S Toyokuni, and K Uchida, and O Ogawa, and J Takenewa, and Y Kakehi, and H Kinoshita, and Y Hattori-Nakakuki, and H Hiai, and O Yoshida
Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal.
January 1996, Chemical research in toxicology,
K Okamoto, and S Toyokuni, and K Uchida, and O Ogawa, and J Takenewa, and Y Kakehi, and H Kinoshita, and Y Hattori-Nakakuki, and H Hiai, and O Yoshida
A synthesis of 4-hydroxy-2-trans-nonenal and 4-(3H) 4-hydroxy-2-trans-nonenal.
July 1997, Lipids,
Copied contents to your clipboard!